Home
ALGS
ALGS News

Latest Aligos Therapeutics Inc. (ALGS) News on July 27, 2024

MT Newswires

4 days ago

Aligos Therapeutics Collaborating With Xiamen Amoytop Biotech in China for Chronic Hepatitis B Patients

Aligos Therapeutics Announces Clinical Collaboration with Xiamen Amoytop Biotech Co., Ltd.

GlobeNewswire

4 days ago

Aligos Therapeutics Announces Clinical Collaboration with Xiamen Amoytop Biotech Co., Ltd.

Aligos Therapeutics to Host KOL Event to Discuss the Positive Phase 1b Data from ALG-000184 for the Treatment of CHB

GlobeNewswire

17 days ago

Aligos Therapeutics to Host KOL Event to Discuss the Positive Phase 1b Data from ALG-000184 for the Treatment of CHB

AbbVie (ABBV) Parkinson's Candidate Faces 2nd FDA Rejection

Zacks

a month ago

AbbVie (ABBV) Parkinson's Candidate Faces 2nd FDA Rejection

GSK's Filing for Expanded Use of Jemperli Gets EMA Acceptance

Zacks

a month ago

GSK's Filing for Expanded Use of Jemperli Gets EMA Acceptance

J&J (JNJ) Seeks Expanded Use of Tremfya for Crohn's Disease

Zacks

a month ago

J&J (JNJ) Seeks Expanded Use of Tremfya for Crohn's Disease

AstraZeneca's (AZN) Truqap Gets EU Nod for Breast Cancer

Zacks

a month ago

AstraZeneca's (AZN) Truqap Gets EU Nod for Breast Cancer

Zentalis (ZNTL) Tanks After FDA Puts 3 Cancer Studies on Hold

Zacks

a month ago

Zentalis (ZNTL) Tanks After FDA Puts 3 Cancer Studies on Hold

AstraZeneca's (AZN) Truqap Misses Endpoints in TNBC Study

Zacks

a month ago

AstraZeneca's (AZN) Truqap Misses Endpoints in TNBC Study

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

GOBankingRates

2 months ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

Bumrah delivers as India beat Pakistan in low-scoring thriller

AFP

2 months ago

Bumrah delivers as India beat Pakistan in low-scoring thriller

Italy beat Bosnia in final Euros warm-up

AFP

2 months ago

Italy beat Bosnia in final Euros warm-up

Macron Calls French Legislative Election After Far-Right Surge

Bloomberg

2 months ago

Macron Calls French Legislative Election After Far-Right Surge

Trump loyalists proud to support 'felon' at Las Vegas rally

AFP

2 months ago

Trump loyalists proud to support 'felon' at Las Vegas rally

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

Business Insider

2 months ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women

Insider Monkey

2 months ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Reuters

2 months ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Aligos Therapeutics Presents Positive Data at the EASL Congress 2024

GlobeNewswire

2 months ago

Aligos Therapeutics Presents Positive Data at the EASL Congress 2024

Here's Why Aligos Therapeutics (ALGS) Is a Great 'Buy the Bottom' Stock Now

Zacks

2 months ago

Here's Why Aligos Therapeutics (ALGS) Is a Great 'Buy the Bottom' Stock Now

Aligos Therapeutics Announces Six Abstracts Accepted for Presentation at EASL 2024

GlobeNewswire

2 months ago

Aligos Therapeutics Announces Six Abstracts Accepted for Presentation at EASL 2024

Aligos Therapeutics Announces the Completion of Enrollment in the ALG-055009 Phase 2a HERALD Study for the Treatment of MASH

GlobeNewswire

2 months ago

Aligos Therapeutics Announces the Completion of Enrollment in the ALG-055009 Phase 2a HERALD Study for the Treatment of MASH

After Plunging -13.71% in 4 Weeks, Here's Why the Trend Might Reverse for Aligos Therapeutics (ALGS)

Zacks

2 months ago

After Plunging -13.71% in 4 Weeks, Here's Why the Trend Might Reverse for Aligos Therapeutics (ALGS)

Aligos Therapeutics First Quarter 2024 Earnings: US$0.22 loss per share (vs US$0.54 loss in 1Q 2023)

Simply Wall St.

3 months ago

Aligos Therapeutics First Quarter 2024 Earnings: US$0.22 loss per share (vs US$0.54 loss in 1Q 2023)

Aligos Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results

GlobeNewswire

3 months ago

Aligos Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results

Aligos Therapeutics to Announce 1st Quarter 2024 Financial Results on May 7, 2024

GlobeNewswire

3 months ago

Aligos Therapeutics to Announce 1st Quarter 2024 Financial Results on May 7, 2024

Aligos Therapeutics Presents Positive Clinical Data at ESCMID 2024 from the ALG-097558 Phase 1 Study

GlobeNewswire

3 months ago

Aligos Therapeutics Presents Positive Clinical Data at ESCMID 2024 from the ALG-097558 Phase 1 Study

Aligos Therapeutics Mourns the Passing of MASH Industry Leader Stephen A. Harrison, MD

GlobeNewswire

3 months ago

Aligos Therapeutics Mourns the Passing of MASH Industry Leader Stephen A. Harrison, MD

Aligos Therapeutics to Participate in the Piper Sandler Spring Biopharma Symposium 2024

GlobeNewswire

4 months ago

Aligos Therapeutics to Participate in the Piper Sandler Spring Biopharma Symposium 2024

Aligos Therapeutics Announces First Subjects Dosed in the Phase 2a HERALD Study of ALG-055009 in MASH Subjects

GlobeNewswire

4 months ago

Aligos Therapeutics Announces First Subjects Dosed in the Phase 2a HERALD Study of ALG-055009 in MASH Subjects

Aligos Therapeutics, Inc. (ALGS) Just Flashed Golden Cross Signal: Do You Buy?

Zacks

4 months ago

Aligos Therapeutics, Inc. (ALGS) Just Flashed Golden Cross Signal: Do You Buy?

Aligos Therapeutics Presents Positive Clinical Data at APASL 2024 from ALG-055009 and ALG-000184 Phase 1 Studies

GlobeNewswire

4 months ago

Aligos Therapeutics Presents Positive Clinical Data at APASL 2024 from ALG-055009 and ALG-000184 Phase 1 Studies

Aligos Therapeutics Announces the Initiation of the Phase 2a HERALD Study of ALG-055009 in MASH Subjects

GlobeNewswire

4 months ago

Aligos Therapeutics Announces the Initiation of the Phase 2a HERALD Study of ALG-055009 in MASH Subjects

Aligos Therapeutics Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

4 months ago

Aligos Therapeutics Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire

4 months ago

Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results

Aligos Therapeutics to Announce 4th Quarter 2023 Financial Results on March 12, 2024

GlobeNewswire

5 months ago

Aligos Therapeutics to Announce 4th Quarter 2023 Financial Results on March 12, 2024

Aligos Therapeutics To Participate in the Leerink Partners Global Biopharma Conference 2024

GlobeNewswire

5 months ago

Aligos Therapeutics To Participate in the Leerink Partners Global Biopharma Conference 2024

Aligos Therapeutics to Host KOL Event to Discuss Phase 2a HERALD Study of ALG-055009 in MASH on March 7, 2024

GlobeNewswire

5 months ago

Aligos Therapeutics to Host KOL Event to Discuss Phase 2a HERALD Study of ALG-055009 in MASH on March 7, 2024

Aligos Therapeutics Strengthens Finance Leadership Team with Two New Appointments

GlobeNewswire

5 months ago

Aligos Therapeutics Strengthens Finance Leadership Team with Two New Appointments

After losing 41% in the past year, Neuronetics, Inc. (NASDAQ:STIM) institutional owners must be relieved by the recent gain

Simply Wall St.

6 months ago

After losing 41% in the past year, Neuronetics, Inc. (NASDAQ:STIM) institutional owners must be relieved by the recent gain

D-Wave Quantum to Present at 26th Annual Needham Growth Conference

NewMediaWire

6 months ago

D-Wave Quantum to Present at 26th Annual Needham Growth Conference

Is Aligos Therapeutics (ALGS) Stock Outpacing Its Medical Peers This Year?

Zacks

7 months ago

Is Aligos Therapeutics (ALGS) Stock Outpacing Its Medical Peers This Year?

Those who invested in Abeona Therapeutics (NASDAQ:ABEO) a year ago are up 98%

Simply Wall St.

7 months ago

Those who invested in Abeona Therapeutics (NASDAQ:ABEO) a year ago are up 98%

Expensify Adds Budgeting to Help Companies Prepare for 2024

Business Wire

7 months ago

Expensify Adds Budgeting to Help Companies Prepare for 2024

Amundi US Declares Monthly Distributions for Pioneer Closed-End Funds

Business Wire

7 months ago

Amundi US Declares Monthly Distributions for Pioneer Closed-End Funds

GlobeNewswire

7 months ago

Diamond Equity Research Releases Update Note on QuantaSing Group Limited (NASDAQ: QSG)

A Closer Look At QuantaSing Group Limited's (NASDAQ:QSG) Impressive ROE

Simply Wall St.

7 months ago

A Closer Look At QuantaSing Group Limited's (NASDAQ:QSG) Impressive ROE

After losing 78% in the past year, BioAtla, Inc. (NASDAQ:BCAB) institutional owners must be relieved by the recent gain

Simply Wall St.

7 months ago

After losing 78% in the past year, BioAtla, Inc. (NASDAQ:BCAB) institutional owners must be relieved by the recent gain

Investors in Ribbon Communications (NASDAQ:RBBN) have unfortunately lost 65% over the last three years

Simply Wall St.

8 months ago

Investors in Ribbon Communications (NASDAQ:RBBN) have unfortunately lost 65% over the last three years

Aligos Therapeutics Presents Positive Clinical Data at Hep-DART 2023 from Phase 1 Studies in HBV (ALG-000184) and NASH (ALG-055009)

GlobeNewswire

8 months ago

Aligos Therapeutics Presents Positive Clinical Data at Hep-DART 2023 from Phase 1 Studies in HBV (ALG-000184) and NASH (ALG-055009)

MediciNova Receives a Notice of Decision to Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Progressive MS in Europe

GlobeNewswire

8 months ago

MediciNova Receives a Notice of Decision to Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Progressive MS in Europe

Yatra Online, Aramco Asia Join Hands to Address Regional Travel Demand

PR Newswire

8 months ago

Yatra Online, Aramco Asia Join Hands to Address Regional Travel Demand

13 Stocks Insiders are Buying Now

Insider Monkey

8 months ago

13 Stocks Insiders are Buying Now

Mesoblast (MESO) Up on Deal With BMT CTN to Develop GVHD Drug

Zacks

8 months ago

Mesoblast (MESO) Up on Deal With BMT CTN to Develop GVHD Drug

Aligos Therapeutics To Present at the Piper Sandler Healthcare Conference

GlobeNewswire

8 months ago

Aligos Therapeutics To Present at the Piper Sandler Healthcare Conference

B. Riley Financial, Inc. Bolsters Position in Babcock & Wilcox Enterprises Inc

GuruFocus.com

8 months ago

B. Riley Financial, Inc. Bolsters Position in Babcock & Wilcox Enterprises Inc

UPDATE: ICZOOM to Present at Benchmark Company's Annual Investor Conference

PR Newswire

8 months ago

UPDATE: ICZOOM to Present at Benchmark Company's Annual Investor Conference

South China Morning Post

8 months ago

Lufax to acquire Hong Kong virtual lender Ping An OneConnect Bank for US$119.5 million

OneConnect Announces Third Quarter and Nine Months Ended September 30, 2023 Unaudited Financial Results

PR Newswire

8 months ago

OneConnect Announces Third Quarter and Nine Months Ended September 30, 2023 Unaudited Financial Results

GlobeNewswire

8 months ago

Aligos Therapeutics Presents Clinical and Nonclinical Data at the AASLD Liver Meeting® 2023 Demonstrating that ALG-055009 has a Favorable Risk-Benefit Profile

Aligos Therapeutics Presents Positive Data at the AASLD Liver Meeting® 2023 Demonstrating that Treatment with ALG-000184 (CAM-E) Results in Significant Multi-log Reductions in Hepatitis B Antigens (HBsAg, HBcrAg and HBeAg)

GlobeNewswire

9 months ago

Aligos Therapeutics Presents Positive Data at the AASLD Liver Meeting® 2023 Demonstrating that Treatment with ALG-000184 (CAM-E) Results in Significant Multi-log Reductions in Hepatitis B Antigens (HBsAg, HBcrAg and HBeAg)

Thomson Reuters StreetEvents

9 months ago

Q1 2024 Matrix Service Co Earnings Call

Applied Therapeutics Inc (APLT) Reports Q3 2023 Financial Results Amidst Upcoming Clinical ...

GuruFocus.com

9 months ago

Applied Therapeutics Inc (APLT) Reports Q3 2023 Financial Results Amidst Upcoming Clinical ...

Associated Press Finance

9 months ago

Matrix Service: Fiscal Q1 Earnings Snapshot

Aligos Therapeutics to Present Multiple Posters at AASLD’s The Liver Meeting® 2023, Highlighting Progress for Its Clinical Stage Portfolio, including Lead THR-β Agonist for the Treatment of NASH, ALG-055009; ALG-000184, the Company’s Lead CAM-E Molecule, and Updates on Several Preclinical Candidates for the Treatment of Chronic Hepatitis B, in Addition to the Recently Announced Late Breaker Poster (#5028-C)

GlobeNewswire

9 months ago

Aligos Therapeutics to Present Multiple Posters at AASLD’s The Liver Meeting® 2023, Highlighting Progress for Its Clinical Stage Portfolio, including Lead THR-β Agonist for the Treatment of NASH, ALG-055009; ALG-000184, the Company’s Lead CAM-E Molecule, and Updates on Several Preclinical Candidates for the Treatment of Chronic Hepatitis B, in Addition to the Recently Announced Late Breaker Poster (#5028-C)

Allurion to Participate in the Jefferies London Healthcare Conference

Business Wire

9 months ago

Allurion to Participate in the Jefferies London Healthcare Conference

Share on Social Networks: